Stocktoria

Quoin Pharmaceuticals, Ltd. QNRX

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 1989-11-01

Quoin Pharmaceuticals, Ltd. statistics & valuation

Market cap$8.2M
P / B0.6×
Return on equity-120.5%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
202020212022202320242025
Operating margin (%)
202020212022202320242025
Return on equity (%)
-3266.60% -126.70% -153.40% -97.40% -120.50% 202020212022202320242025
Shares outstanding
1.20B 3.35B 403887 987220 8.9M 52.4M 202020212022202320242025
Net debt ($)
202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-152.10% -229.40% -64.90% -71.40% -57.10% -77.50% 202020212022202320242025
Free cash flow margin (%)
202020212022202320242025
Debt / equity (×)
202020212022202320242025
EPS ($)
-$0.70 -$0.01 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Return on assets-77.5%-57.1%-71.4%-64.9%-229.4%-152.1%
Return on equity-120.5%-97.4%-153.4%-126.7%-3266.6%31.7%
Current ratio3.613.573.153.791.79—

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.